Andreas Marinelli
Papers
1
Total Citations
84
H-Index
1
About
Andreas Marinelli is a leading colorectal surgeon whose work has fundamentally advanced the safety of minimally invasive surgery. His primary research focuses on intraoperative imaging, particularly the use of indocyanine green (ICG) near-infrared fluorescence to assess bowel perfusion—a critical factor in preventing anastomotic leakage, a devastating complication in colorectal procedures. Marinelli’s most impactful contribution is the landmark AVOID trial, a multicentre, randomised, phase 3 study published in 2024. This trial demonstrated that real-time fluorescence angiography significantly reduces the rate of anastomotic leakage, providing robust, evidence-based guidance for surgeons worldwide. With 84 citations in its first year, the AVOID trial has already become a cornerstone reference in the field. Marinelli’s work bridges the gap between innovative imaging technology and tangible patient outcomes, earning him recognition as a pioneer in precision surgery. His research not only improves recovery and reduces morbidity but also sets a new standard for intraoperative decision-making, making him a vital figure for any student or researcher interested in the future of surgical safety and evidence-based practice.
Research Focus
Key Achievements
Top Papers
- 1